Navigation Links
Anti-malaria drug synthesized with the help of oxygen and light
Date:1/17/2012

This release is available in German.

The most effective anti-malaria drug can now be produced inexpensively and in large quantities. This means that it will be possible to provide medication for the 225 million malaria patients in developing countries at an affordable price. Researchers at the Max Planck Institute of Colloids and Interfaces in Potsdam and the Freie Universitt Berlin have developed a very simple process for the synthesis of artemisinin, the active ingredient that pharmaceutical companies could only obtain from plants up to now. The chemists use a waste product from current artemisinin production as their starting substance. This substance can also be produced biotechnologically in yeast, which the scientists convert into the active ingredient using a simple yet very ingenious method.

There is an effective treatment against malaria, but it is not accessible to all of the more than 200 million people worldwide who are affected by the disease. Millions, especially in the developing world, cannot afford the combination drug preparation, which consists mainly of artemisinin. Moreover, the price for the medication varies, as this substance is isolated from sweet wormwood (Artemisia annua) which grows mainly in China and Vietnam, and varies seasonally in its availability. To make the drug affordable for at least some patients in developing countries, the Clinton Foundation, for example, subsidises its cost to the tune of several million dollars per year. Nevertheless, over one million people die of malaria each year because they do not have access to effective drugs.

This may be about to change. Peter H. Seeberger, Director at the Max Planck Institute of Colloids and Interfaces in Potsdam and Professor of Chemistry at the Freie Universitt Berlin and his colleague Franois Lvesque have discovered a very simple way of synthe
'/>"/>

Contact: Dr. Peter Seeberger
peter.seeberger@mpikg.mpg.de
49-331-567-9301
Max-Planck-Gesellschaft
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Synthetic biology can help extend anti-malaria drug effectiveness
2. New nano-tool synthesized at Scripps Research Institute
3. Path to oxygen in Earths atmosphere: long series of starts and stops
4. How plants sense low oxygen levels to survive flooding
5. New evidence for the oldest oxygen-breathing life on land
6. Discovery suggests way to block fetal brain damage produced by oxygen deprivation
7. MIT: Oxygens watery past
8. Climate change could turn oxygen-free seas from blessing to curse for zooplankton
9. Oceans harmful low-oxygen zones growing, are sensitive to small changes in climate
10. Johns Hopkins researchers link cell division and oxygen levels
11. Beneficial bacteria help repair intestinal injury by inducing reactive oxygen species
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anti-malaria drug synthesized with the help of oxygen and light
(Date:8/21/2014)... 18-22, 2014 , WHERE: , San Diego ... CA 92101 , WHAT: , Invited and ... latest research in human genetics. Examples of sessions ... on rare genetic variants in health and disease, ... sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , ...
(Date:8/21/2014)... the journal Carcinogenesis by researchers at the ... protein adenomatous polyposis coli (APC) in suppressing colorectal cancer ... U.S. , Lead author Kristi Neufeld, associate professor in ... Cancer Biology program at the KU Cancer Center, has ... understand the various activities of APC, a protein whose ...
(Date:8/21/2014)... designed by an international standards process, will be available ... an invited review published in the OnlineFirst version of ... the official journal of the American Society for Parenteral ... reduce the occurrence of misconnection that can be harmful ... are used to join medical devices, components, and accessories ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3New feeding tube connectors will improve patient safety 2
... at Universitat Autnoma de Barcelona (INc-UAB) identified the fundamental ... associated with synaptic activity. The discovery, published in the ... study a new target that could help to understand ... known to cause early cognitive deficit, and the neurodegeneration ...
... NC In a paper published today in the journal ... North Carolina at Chapel Hill demonstrates a simple, cost-effective technique ... the structures, and ultimately the functions, of the RNA molecules ... When cell behavior goes wrong, diseases including cancer and ...
... gene sequencing technology, researchers have demonstrated that the gene ... Leukemia, AML, one of the most common types of ... allows for the rapid and comprehensive detection of gene ... online April 15 in Nature , are a ...
Cached Biology News:Researchers have identified a gene with a key role in neuronal survival 23-D RNA modeling opens scientific doors 2Scientists identify FLT3 gene as a valid therapeutic target in acute myeloid leukemia 2
(Date:8/20/2014)... RALEIGH, N.C. , Aug. 20, 2014 /PRNewswire/ ... clinical research services located in Raleigh, ... Bradford Evans as Vice President of ... Administration, Brad will oversee all corporate processes, including ... to joining Clintrax Global, Brad worked as an ...
(Date:8/20/2014)... measuring vibrational motion of a single molecule with a ... a single molecule differs from the behaviour of larger ... the University of California, Irvine, where post-doctoral researcher Eero ... visiting fellow under professor Vartkess A. Apkarian, whose team ... by Professor Eric O. Potma. The results of the ...
(Date:8/20/2014)... -- Decision Resources Group finds that the vascular access device market in ... India and China (BRIC) ... the size of the United States market ... faster growth as a result of strong economic expansion, improving access ... from Decision Resources Group,s coverage of the BRIC vascular access device ...
(Date:8/20/2014)... Not long ago, it was more or ... late in the development cycle – even after the ... suggest that, like many things GxP, expectations for early ... multiple drug sponsors have been required by authorities to ... phase I/II. It’s not only clinical trial material containers ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Seeing a molecule breathe 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... N.J., Sept. 12 Schering-Plough,Corporation (NYSE: SGP ) ... aggregate principal amount of 6.00% Senior Notes due 2017 ... due 2037 through,an underwritten registered public offering. The offering ... customary closing conditions. The global coordinator for the ...
... Inc.,(Nasdaq: MEDX ) announced today that it is ... Growth Conference in New York City on Tuesday,September 18, ... be,webcast live and will be available for replay through ... Medarex website via the Internet at, http://www.medarex.com . ...
... SAN DIEGO, Sept. 12 Gen-Probe Incorporated,(Nasdaq: GPRO ... Bank of,America,s 37th Annual Investment Conference in San Francisco ... (5:30 p.m. Eastern Time).,The presentation is scheduled to be ... the investor information section of Gen-Probe,s website,at http://www.gen-probe.com ...
Cached Biology Technology:Schering-Plough Announces Pricing of Senior Notes Offering 2Schering-Plough Announces Pricing of Senior Notes Offering 3Gen-Probe to Webcast Presentation at Bank of America's 37th Annual Investment Conference 2
... U. Desselberger (1995) • This book ... together classical and molecular techniques currently ... infections and analysis of virus-specific antibodies ... are presented covering immunoassays, blotting and ...
...
... Kits provide rapid and efficient removal of ... and salts from PCR products (Figure 1). ... two Binding Buffer options for fragments >100 ... performed in either single column or 96-well ...
... Blunt TOPO PCR Cloning Kit offers ... high-efficiency (>=95%) cloning of blunt-end PCR ... The kit includes the linearized and ... 5-minute bench-top ligations without ligase (1). ...
Biology Products: